Web NewDrugInformation.com

An-maa Drug - An-maa The trade name of the product as shown on the labeling. Dosage - INJECTABLE; INJECTION The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Technetium Tc-99m Albumin Aggregated Kit Multiple ingredients are in alphabetical order. Strength - N/A The potency of the active ingredient(s), Technetium Tc-99m Albumin Aggregated Kit. May repeat for multiple part products. Applicant - CIS The firm name holding legal responsibility for An-maa. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 017792 The FDA assigned number to An-maa. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify An-maa. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Approved Prior to Jan 1, 1982 The date An-maa was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of An-maa. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - DISCN The group or category of approved drugs An-maa is in. Format is RX, OTC, DISCN. Applicant Full Name - Cis Us Inc The full name of the firm holding legal responsibility for the new application of An-maa. An-maa Tazorac 0.1% Gel; Topical Tc 99m-lungaggregate 5mci/ml Injectable; Injection A-n Stannous Aggregated Albumin N/a Injectable; Injection An-maa N/a Injectable; Injection Tamoxifen Citrate Eq 20mg Base Tablet; Oral Flomax 0.4mg Capsule; Oral Avage 0.1% Cream; Topical Tazorac 0.05% Cream; Topical Tazorac 0.1% Cream; Topical Tazorac 0.05% Gel; Topical NewDrugInformation